However, given the current study, it is reasonable to postulate that loss of Aiolos could also result in altered lymphoid migratory patterns during immune responses to infection or cancer, which would be consistent with findings in human patients harboring Aiolos missense mutations (23–26). This evidence concerns the gene IKZF3 and cancer.